INFIPLAST is an independent company based in the Auvergne Rhône Alpes region, offering expertise in polymer transformation for the medical and industrial sectors. The company specializes in customized, high-value solutions for the health and industrial fields, with a focus on collaborative innovation and full project support from conception to industrialization. INFIPLAST's expertise lies in polymer transformation, ranging from 25T to 600T injections, micro-injection, spiral tube extrusion, and LSR (silicone) in ISO5, ISO7, and ISO8 clean rooms.
The company serves two main sectors: Medical Devices (including cardiology, oncology, diagnostics, ophthalmology, and pneumology) and Industry (such as automotive, home automation, aerospace, and construction). INFIPLAST holds certifications including ISO 13485, ISO 9001, and IATF 16949, ensuring high-quality and compliance standards.
Established in 1988, INFIPLAST is active in the manufacturing, medical devices, space, supply chain, and automotive industries.
INFIPLAST presents an opportunity for investors seeking to support a company with a strong track record in the critical sectors of healthcare and industry, positioning it for potential growth and impact in the market.
There is no investment information
No recent news or press coverage available for INFIPLAST.